Suven Life Sciences Ltd Share Price Target 2026, 2030, 2035 | Updated Aug 2026
Suven Life Sciences Ltd share price today: ₹370.00 | Next market-day median forecast: ₹314.50 (2026-08-27) | 10–90% range: ₹314.50–₹314.50 | Forecast confidence: 76.5% | Chance of upside: 0.0% | Intrinsic value: ₹78.75 | 2027 target: ₹346.85 | 2036 target: ₹300.68
The next market-day median forecast for Suven Life Sciences Ltd (2026-08-27) is ₹314.50 which is 15.00% lower than today’s share price of ₹370.00 with a 10–90% range of ₹314.50–₹314.50. The estimate uses available price history, volatility, trend behaviour and intrinsic value gap.
Interactive Share Price Forecast
Choose tomorrow, day after, weekly, monthly or custom trading-day horizons and adjust assumptions to view possible price ranges.
Scenario controls
Uses trading-day intervals for short-term and long-term forecast views.
1 = next market day, 2 = day after, 21 ≈ one trading month.
Scenario adjusts assumptions for cautious, normal or optimistic market conditions.
Wider bands show more uncertainty; narrower bands show central outcomes.
Higher volatility widens the forecast range.
Higher influence gives more weight to intrinsic value in the forecast.
Target date--
Median forecast--
Expected return--
Selected range--
Chance of upside--
Confidence--
Horizon
Target date
Median forecast
Range
Return
Chance of upside
Forecast guide: Explore possible future price ranges using available price history, intrinsic value trend, volatility and valuation gap. Estimates update as fresh market and valuation data become available.
Suven Life Sciences Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹78.75 vs CMP ₹370.00 (-78.7%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▲ Bullish
Price/EMA: 1.917 · EMA(252): ₹192.97
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
79% annualized
Risk: High · Recent trend: Stable
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Random walk
Hurst exponent: 0.533
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-2.2%5Y-2.1%10Y
Historical drift: +40.2% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.80x
Upside -78.7% vs downside 98% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-369.8%
No margin
Forecast ConfidenceiShows how strongly the forecast is supported by available data, recent forecast behaviour and volatility. Higher confidence means the estimate has better historical support and lower uncertainty.
High (76.5%)
Chance of upside: 0.0% · Avg forecast error: 7.65% · 554 data points
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹7.40
(98% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹127.00
₹370.00
CMP: ₹370.00100% into range0% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows a possible timeline for the stock price to move closer to its intrinsic value. Milestones show estimated prices at 25%, 50%, 75% and 100% convergence. For overvalued stocks, convergence may indicate downside toward intrinsic value.
Target: ₹78.75 in ~5.0 years (2031)
Now ₹37025% ₹29750% ₹22475% ₹152Target ₹79
Gap: 78.7% downward · Assumed convergence period: 5.0 years
What this means: Suven Life Sciences Ltd appears overvalued by 78.7% relative to intrinsic value. The stock is currently in a bullish regime (price above EMA). Volatility is high (79% annualized), implying wider price swings and higher risk.
Suven Life Sciences Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
346.85
-6.3%
-6.3%
Month
Projected Price (₹)
Jan
380.34
Feb
379.76
Mar
371.85
Apr
367.03
May
370.10
Jun
368.48
Jul
361.97
Aug
365.63
Sep
360.50
Oct
351.29
Nov
343.37
Dec
346.85
2028
322.92
-12.7%
-6.6%
Month
Projected Price (₹)
Jan
337.38
Feb
344.13
Mar
339.51
Apr
344.49
May
342.90
Jun
337.89
Jul
328.82
Aug
332.83
Sep
322.92
Oct
319.95
Nov
325.62
Dec
322.92
2029
338.45
-8.5%
-2.9%
Month
Projected Price (₹)
Jan
330.88
Feb
338.08
Mar
330.41
Apr
339.36
May
328.67
Jun
332.64
Jul
329.16
Aug
334.85
Sep
336.96
Oct
337.58
Nov
339.76
Dec
338.45
2030
359.30
-2.9%
-0.7%
Month
Projected Price (₹)
Jan
341.85
Feb
346.56
Mar
349.51
Apr
359.31
May
358.33
Jun
353.62
Jul
348.36
Aug
355.99
Sep
353.02
Oct
353.59
Nov
352.55
Dec
359.30
2031
331.06
-10.5%
-2.2%
Month
Projected Price (₹)
Jan
358.28
Feb
350.97
Mar
356.38
Apr
352.36
May
345.36
Jun
340.45
Jul
333.52
Aug
332.57
Sep
336.86
Oct
336.41
Nov
332.39
Dec
331.06
2032
316.94
-14.3%
-2.5%
Month
Projected Price (₹)
Jan
328.79
Feb
326.81
Mar
332.69
Apr
330.96
May
330.18
Jun
329.94
Jul
325.07
Aug
325.99
Sep
327.35
Oct
329.64
Nov
323.72
Dec
316.94
2033
338.08
-8.6%
-1.3%
Month
Projected Price (₹)
Jan
309.91
Feb
306.59
Mar
313.17
Apr
326.33
May
327.53
Jun
331.38
Jul
323.87
Aug
328.18
Sep
334.99
Oct
338.46
Nov
338.97
Dec
338.08
2034
302.45
-18.3%
-2.5%
Month
Projected Price (₹)
Jan
329.25
Feb
323.60
Mar
322.19
Apr
321.01
May
322.42
Jun
329.82
Jul
321.69
Aug
321.71
Sep
315.14
Oct
311.40
Nov
306.79
Dec
302.45
2035
318.83
-13.8%
-1.6%
Month
Projected Price (₹)
Jan
302.81
Feb
308.44
Mar
307.26
Apr
309.97
May
310.63
Jun
307.87
Jul
307.15
Aug
302.52
Sep
307.65
Oct
306.99
Nov
312.18
Dec
318.83
2036
300.68
-18.7%
-2.1%
Month
Projected Price (₹)
Jan
307.94
Feb
313.15
Mar
309.67
Apr
310.74
May
307.45
Jun
307.32
Jul
306.73
Aug
311.25
Sep
304.39
Oct
301.85
Nov
300.66
Dec
300.68
Suven Life Sciences Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
4.46%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
59.1%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹7.35
PredictionsiTotal number of daily forecasts available for this stock. More observations improve the reliability of accuracy metrics and trend comparison.
Will Suven Life Sciences Ltd share price increase on the next market day?
Suven Life Sciences Ltd median forecast is ₹314.50 on 2026-08-27, which is 15.00% lower than today’s price of ₹370.00. The 10-90% forecast range is ₹314.50 to ₹314.50. Forecast confidence is 76.5%, with probability-up estimate of 0.0%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.
What is the intrinsic value of Suven Life Sciences Ltd?
Suven Life Sciences Ltd intrinsic value is ₹78.75, which is 78.72% below the current price of ₹370.00. This suggests the stock is currently overvalued.
What is the share price target of Suven Life Sciences Ltd in 2027?
Suven Life Sciences Ltd share price target for 2027 is projected to reach ₹346.85 by year-end (range: ₹343.37 to ₹380.34), representing a -6.26% decrease from the current price of ₹370.00.
What is the share price target of Suven Life Sciences Ltd in 2028?
Suven Life Sciences Ltd share price target for 2028 is projected to reach ₹322.92 by year-end (range: ₹319.95 to ₹344.49), representing a -12.72% decrease from the current price of ₹370.00.
What is the share price target of Suven Life Sciences Ltd in 2029?
Suven Life Sciences Ltd share price target for 2029 is projected to reach ₹338.45 by year-end (range: ₹328.67 to ₹339.76), representing a -8.53% decrease from the current price of ₹370.00.
Should I buy Suven Life Sciences Ltd stock now?
Based on current analysis, Suven Life Sciences Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹78.75 vs CMP ₹370.00. Use this as a research input and match it with your risk profile, investment horizon and portfolio plan.
What is the fundamental floor price for Suven Life Sciences Ltd?
The fundamental floor price for Suven Life Sciences Ltd is ₹7.40, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Suven Life Sciences Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Suven Life Sciences Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Suven Life Sciences Ltd
The next market-day price forecast uses price trend, volatility, valuation gap and regime adjustment. The displayed value is the median estimate, supported by a 10–90% uncertainty range.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Suven Life Sciences Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are informational estimates based on available data and assumptions. Past performance does not guarantee future results. Investors should consider risk profile, investment horizon, portfolio allocation and market risks before acting on any research output. Please read all relevant documents and terms carefully before investing.